149 related articles for article (PubMed ID: 25844942)
1. IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.
Estrabaud E; Appourchaux K; Bièche I; Carrat F; Lapalus M; Lada O; Martinot-Peignoux M; Boyer N; Marcellin P; Vidaud M; Asselah T
PLoS One; 2015; 10(4):e0121395. PubMed ID: 25844942
[TBL] [Abstract][Full Text] [Related]
2. Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.
Estrabaud E; Lapalus M; Broët P; Appourchaux K; De Muynck S; Lada O; Martinot-Peignoux M; Bièche I; Valla D; Bedossa P; Marcellin P; Vidaud M; Asselah T
J Virol; 2014 Jun; 88(11):6394-402. PubMed ID: 24672032
[TBL] [Abstract][Full Text] [Related]
3. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.
Asselah T; Bieche I; Narguet S; Sabbagh A; Laurendeau I; Ripault MP; Boyer N; Martinot-Peignoux M; Valla D; Vidaud M; Marcellin P
Gut; 2008 Apr; 57(4):516-24. PubMed ID: 17895355
[TBL] [Abstract][Full Text] [Related]
4. Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(3):e0120794. PubMed ID: 25790297
[TBL] [Abstract][Full Text] [Related]
5. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
Cornberg M; Hadem J; Herrmann E; Schuppert F; Schmidt HH; Reiser M; Marschal O; Steffen M; Manns MP; Wedemeyer H
J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.
Farag RE; Arafa MM; El-Etreby S; Saudy NS; Eldeek BS; El-Alfy HA; Goda IF; Ali RM
Arch Iran Med; 2013 Feb; 16(2):68-73. PubMed ID: 23360626
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patients.
Motawi TM; Rizk SM; Shaker OG; Mokhtar OZ
PLoS One; 2015; 10(3):e0121524. PubMed ID: 25811198
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
[TBL] [Abstract][Full Text] [Related]
10. Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/ribavirin.
Miyasaka A; Kumagai I; Abe K; Suzuki K
Hepatogastroenterology; 2012 May; 59(115):794-9. PubMed ID: 22020909
[TBL] [Abstract][Full Text] [Related]
11. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
[TBL] [Abstract][Full Text] [Related]
12. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
13. [Genomic diversity of the genotype 1b hepatitis C virus open reading frame is correlated with outcomes of combined pegylated-interferon/ribavirin therapy in patients with chronic hepatitis C from Henan Province].
Zeng Y; Kang Y; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):401-6. PubMed ID: 25203700
[TBL] [Abstract][Full Text] [Related]
14. [MiR-196a-2 gene polymorphism and the antiviral therapy of chronic hepatitis C].
Hong XL; Cao H; Zhao F; Pan XF; Zhang K; Xu QH; Zhao ZX; Li G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):470-2. PubMed ID: 21604580
[TBL] [Abstract][Full Text] [Related]
15. Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.
Noureddin M; Rotman Y; Zhang F; Park H; Rehermann B; Thomas E; Liang TJ
Genes Immun; 2015; 16(5):321-9. PubMed ID: 26020282
[TBL] [Abstract][Full Text] [Related]
16. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
Holmes JA; Congiu M; Bonanzinga S; Sandhu MK; Kia YH; Bell SJ; Nguyen T; Iser DM; Visvanathan K; Sievert W; Bowden DS; Desmond PV; Thompson AJ
Aliment Pharmacol Ther; 2015 Aug; 42(3):296-306. PubMed ID: 26032235
[TBL] [Abstract][Full Text] [Related]
17. Factors Affecting the Virological Response Among Chronic Hepatitis C Virus Patients in Yemen.
Alezzi ZMM; Abd El Rehim AY; Fathallah WF; Alamrani MA; Othman FH
J Interferon Cytokine Res; 2018 Jan; 38(1):38-44. PubMed ID: 29328881
[TBL] [Abstract][Full Text] [Related]
18. Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C.
Murakami Y; Tanaka M; Toyoda H; Hayashi K; Kuroda M; Tajima A; Shimotohno K
BMC Med Genomics; 2010 Oct; 3():48. PubMed ID: 20969775
[TBL] [Abstract][Full Text] [Related]
19. [The value of genetics in the era of hepatitis C triple therapy].
Quiles-Pérez R; Pavón-Castillero EJ; Muñoz-de-Rueda P; Carmona I; Salmerón J
Gastroenterol Hepatol; 2014; 37(7):427-37. PubMed ID: 24948442
[TBL] [Abstract][Full Text] [Related]
20. Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.
Abe H; Hayes CN; Ochi H; Tsuge M; Miki D; Hiraga N; Imamura M; Takahashi S; Kubo M; Nakamura Y; Kamatani N; Chayama K
J Med Virol; 2011 Sep; 83(9):1597-607. PubMed ID: 21739451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
